Luye Pharma's U.S. Sales Team Offline Training Session And The Erzofri Internal Launch Event Were Successfully Concluded

Recently, the U.S. sales team’s offline training session and the internal launch meeting for Erzofri® were successfully held, bringing everyone together to actively prepare for the drug’s sales across various U.S. regions.

With the Erzofri® U.S. commercialization team now in place, related efforts—including insurance coverage, market access, medical affairs, training, and marketing—are progressing as planned. The entire team is working collaboratively to accelerate the promotion of Erzofri® in the U.S., aiming to bring this treatment to more American patients as soon as possible.

The 27th Training Course on Standardized Operation of Endoscopic Technology

in Plastic and Aesthetic Surgery Concluded Successfully in Celebright

In order to standardize and improve the application of endoscopic technology in plastic and aesthetic surgery, the 27th Training Course on Standardized Operation of Endoscopic Technology was grandly launched at Shanghai Celebright Plastic Hospital on March 29th and 30th.

Professor Jiang Hua, the Honorary President of the Plastic and Aesthetic Branch of the Chinese Medical Doctor Association and the President of Celebright Hospital, together with other senior plastic surgeons, brought a knowledge feast of theory and practice to plastic surgeons from all over the country.

The practical demonstration teaching of this training course was carried out in the hundred - level laminar flow operating room of Celebright Hospital, and Celebright provided a real – time live broadcast of the whole operation process.

Ellium functional anti-aging center officially launched

On April 19th, the Weight Loss, Metabolism and Functional Anti - Aging International Academic Forum and the Open Ceremony of the Ellium Functional Anti - Aging Center were grandly held in Yantai. Nearly 200 people, including officers from the Yantai City and Gaoxin District governments and the Health Commission, experts in health management, as well as industry representatives attended the event. 

At present, the national "Weight Management Year" is being vigorously promoted, and the national health campaign has set off a boom. The demands for weight loss, anti - glycation and anti - aging have become the core topics of global health management.

The Luye Medical·Yantai Aimeili - Functional Anti - Aging Center emerged at the right time. As the first medical - grade anti - aging platform in Yantai that focuses on the entire life cycle of women, it takes "regulation of the metabolism - inflammation - aging axis" as the scientific paradigm and constructs a three - level progressive health management system of basic - level intervention, precise - level breakthrough and clinical - level innovation. It provides effective and personalized anti - aging, weight - loss, blood sugar control and body - shaping diagnosis and treatment for obese and sub - healthy people of different ages.

At the scene, the Ellium Functional Anti-Aging Center signed strategic cooperation agreements with several companies, will carry out multi - level technical cooperation and medical research in the field of health management to jointly address the huge challenges to human health posed by factors such as functional decline, obesity, chronic diseases, sub-health, genetics and metabolism, and provide professional diagnosis and treatment.

Liu Aona, the Executive Chairman of Luye Medical Group, sent congratulations online on the successful holding of the forum and the official launch of the center.

She said: "In the past decade, global anti-aging science has achieved a cognitive leap from symptom management to system regulation. It is shifting from simply extending lifespan to enhancing health span. The Ellium Functional Anti-Aging Center is an important unit of Luye Medical's health strategy and an important platform for fulfilling the group's mission of ' Care for Brighter Life'. We will actively cooperate with multiple parties to make anti-aging science a health solution that can benefit the public and provide physiological youth - like services with a greater sense of life quality."

Luye Diagnostics Showcases Second-Generation HIV Drug Resistance Testing Innovation at the 10th National AIDS Conference

On April 12, 2025, the 10th National AIDS Conference, organized by the Chinese Association of STD and AIDS Prevention and Control, grandly opened in Zhuhai. As one of the most influential academic events in China's HIV/AIDS prevention and treatment field, this year's conference brought together over 3,000 multidisciplinary representatives from home and abroad to discuss the latest scientific achievements and future directions in HIV/AIDS prevention and treatment.

Luye Diagnostics attracted significant attention at the exhibition with one of its core products—the HIV-1 Drug Resistance Genotyping Kit. Based on NGS (Next-Generation Sequencing) technology, the kit comprehensively covers 276 mutation sites, enabling precise detection of HIV-1 drug resistance and providing robust technical support for clinical precision treatment.